#omicstechnology | Explore Tumblr posts and blogs

ruchinoni · 7 months ago

Text

0 notes

market-insider · 10 months ago

Text

Proteomics Market Forecast: Technological Advancements Shaping the Future

The global proteomics market size is expected to reach USD 58.16 billion by 2030, registering a CAGR of 13.10% from 2024 to 2030, according to a new report by Grand View Research, Inc. The major factors driving theindustry growth are a rise in the demand for personalized medicine, an expansion of the pipeline of diagnostics utilizing proteomics mass spectrometry as well as biochip platforms, and discoveries based on genomics. Moreover, owing to the importance of proteomics in drug development, numerous pharmaceutical companies have established their own proteomic divisions, which are fueling the expansion of the global industry. For instance, in September 2021, Biognosys, announced the collaboration with Evotec, to promote the use of next-generation proteomics in clinical research and drug discovery.

The COVID-19 outbreak is expected to have a significant impact on the industry, as researchers across the world are concentrating on decoding 3D structures of SARS-CoV-2 proteins. To create effective medications and biological products against COVID-19, scientists are also attempting to examine the identification techniques, structures, characterization, and interactions of these proteins. The protein structure of virus proteins and their specific locations must be understood to find a novel, efficient target treatment medication for a virus. Therefore, it will increase the demand for drug development for COVID-19 and propel industry growth. The growing need for customized medications increased R&D spending, and technological developments related to proteomics components are also driving the market.

In addition, attractive market expansion potential for proteomics is anticipated to come from improvements in mass spectrometry-based proteomics and lucrative opportunities related to biomarker identification. Thereby, propelling the market growth.The introduction of new and improved proteomics techniques by major industry participants is projected to further accelerate the growth of the industry. For instance, to provide quick data acquisition for shotgun proteomics, Bruker Corp. introduced the timsTOF Pro system for Parallel Accumulation And Serial Fragmentation (PASEF) mass spectrometry in September 2017. This system uses proprietary Trapped Ion Mobility Spectrometry (TIMS) technology.Furthermore, proteomic research advancements have accelerated the detection of protein biomarkers, protein biochips & pharmacoproteomics, and proteomics-based molecular diagnostics, which have all made significant contributions to the development of personalized medicine.

For More Details or Sample Copy please visit link @: Proteomics Market Report

Proteomics Market Report Highlights

The reagent & consumables product segment held the largest share in 2023 due to rising research activities and the growing demand for protein separation from complicated mixtures for efficient analysis

The clinical diagnostics application segment held a larger share in 2023 due to the development of sophisticated & specialized tests for early disease detection and disease management

The spectroscopy technology segment held the maximum share in 2023 owing to the increasing usage in toxicological response profiling, basic molecular biology, biomarker identification, and pharmaceutical target screening

North America led the global industry in 2023 due to a rise in demand for personalized drugs, the existence of major players operating in the U.S. and a highly developed healthcare research framework, and substantial expenditure on R&D

Asia Pacific is expected to grow at the highest CAGR over the projected period due to factors, such as the rising prevalence of target diseases, increasing aging population, and rising proteomics adoption

Gain deeper insights on the market and receive your free copy with TOC now @: Proteomics Market Report

We have segmented the global proteomics market based on Product & services, application, technology, region.

#Proteomics #ProteomicsMarket #Biotechnology #MarketAnalysis #PrecisionMedicine #DrugDiscovery #ProteomicsResearch #MarketTrends #ProteomicsTechnologies #HealthcareInnovation #ProteomicsApplications #GlobalMarketInsights #MolecularBiology #OmicsTechnologies #ProteomicsIndustry

0 notes

lovelypol · 7 months ago

Text

Precision Diagnostics Market: From $57.5B (2023) to $157.2B (2033), CAGR 10.5%.

Precision Diagnostics Market : Precision diagnostics is an advanced approach to medical testing that utilizes cutting-edge technologies to provide accurate, individualized insights into a patient’s health. By integrating genetic, molecular, and imaging data, this method allows healthcare professionals to detect diseases early, predict risks, and tailor treatment plans to the unique needs of each patient. Unlike traditional diagnostics, precision diagnostics focuses on uncovering the underlying causes of conditions, enabling more effective prevention and treatment strategies.

To Request Sample Report: https://www.globalinsightservices.com/request-sample/?id=GIS22118 &utm_source=SnehaPatil&utm_medium=Article

The market segments within precision diagnostics include genetic testing, molecular diagnostics, imaging diagnostics, and liquid biopsy technologies. These tools are applied across various therapeutic areas, such as oncology, cardiology, neurology, and infectious diseases. Among the key trends are the rise of next-generation sequencing (NGS), the integration of artificial intelligence (AI) in diagnostic processes, and the increasing adoption of liquid biopsies for non-invasive cancer screening. Additionally, the push toward personalized medicine and companion diagnostics is reshaping healthcare delivery.

Key drivers propelling the precision diagnostics market include the growing prevalence of chronic and genetic diseases, advancements in omics technologies, and increasing demand for early disease detection. Expanding healthcare budgets in emerging economies and heightened awareness of precision medicine further bolster market growth. Leading companies in this space include Illumina, Inc., Roche Diagnostics, Thermo Fisher Scientific, Siemens Healthineers, QIAGEN, and GE HealthCare.

#PrecisionDiagnostics #PersonalizedMedicine #NextGenSequencing #MolecularDiagnostics #AIinHealthcare #LiquidBiopsy #CancerScreening #EarlyDetection #OmicsTechnologies #ChronicDiseaseCare #InnovativeHealthcare #DiagnosticRevolution #PatientCentricCare #HealthcareTrends #MedicalInnovation

0 notes